Loading
Life sciences · Interventional Study
ClinicalTrials.gov · November 6, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07920692). This is a study registration, not published results. Lead sponsor: Henan University of Traditional Chinese Medicine. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 320 participants (ESTIMATED). Conditions: Sepsis. Interventions: DRUG: Syndrome-Differentiated Chinese Herbal Medicine; DRUG: Matching Placebo for Syndrome-Differentiated Chinese Herbal Medicine. Primary outcome measures: 28-Day All-Cause Mortality , Day 28 after enrollment; Sequential Organ Failure Assessment (SOFA) Score , Baseline (Day 0), Day 7, Day 14, and Day 28 after enrollment. Brief summary: This study aims to evaluate the clinical efficacy and safety of integrated traditional Chinese and Western medicine in the treatment of sepsis, explore its potential value in improving clinical outcomes, and provide high-quality clinical evidence for the integrated management of sepsis.In addition, blood samples will be collected for phenotyping and subsequent transcriptomic, proteomic, and metabolomic analyses.